E-LIB Suche - Ergebnisse für: Piscaglia, F.

1

Non-selective beta-blockers lower the risk of first decompe..:

Turco, L. ; Taru, M.G. ; Vitale, G....
Digestive and Liver Disease. 56 (2024) - p. S2 , 2024

Link: https://doi.org/10.1016/..

2

Aetiology of hepatocellular carcinoma and response to immun..:

Tovoli, F. ; Chen, R. ; Vivaldi, C....
Digestive and Liver Disease. 56 (2024) - p. S92-S93 , 2024

Link: https://doi.org/10.1016/..

3

Can AtezoBev be a safe and effective option for treating he..:

Stella, L. ; Pallozzi, M. ; Cerrito, L....
Digestive and Liver Disease. 56 (2024) - p. S78 , 2024

Link: https://doi.org/10.1016/..

4

CXCL3 is a target of miR-30e-3p and predicts tumor escape i..:

Vianello, C. ; Leoni, I. ; Galvani, G....
Digestive and Liver Disease. 56 (2024) - p. S94 , 2024

Link: https://doi.org/10.1016/..

5

Management of portal hypertension in patients receiving ate..:

Tovoli, F. ; Franceschini, E. ; Vivaldi, C....
Digestive and Liver Disease. 56 (2024) - p. S87 , 2024

Link: https://doi.org/10.1016/..

6

Efficacy and safety of atezolizumab/bevacizumab for hepatoc..:

Tovoli, F. ; Vivaldi, C. ; Federico, P....
Digestive and Liver Disease. 56 (2024) - p. S85-S86 , 2024

Link: https://doi.org/10.1016/..

7

The impact of etiology on patterns of progression of advanc..:

Stefanini, B. ; Piscaglia, F. ; Dalbeni, A....
Digestive and Liver Disease. 56 (2024) - p. S17 , 2024

Link: https://doi.org/10.1016/..

8

Clinical impact of CEUS on non-characterizable observations..:

Kono, Yuko ; Piscaglia, F. ; Wilson, S. R....
Abdominal Radiology. , 2024

Link: https://doi.org/10.1007/..

9

The synergic effect of metformin with atezolizumab/ bevaciz..:

Dalbeni, A. ; Vicardi, M. ; Natola, L.A....
Digestive and Liver Disease. 56 (2024) - p. S89-S90 , 2024

Link: https://doi.org/10.1016/..

10

MiR-22 regulates HIF-1A pathway and tumor progression and r..:

Galvani, G. ; Leoni, I. ; Monti, E....
Digestive and Liver Disease. 56 (2024) - p. S96-S97 , 2024

Link: https://doi.org/10.1016/..

11

185P The combined role of patients (pts) gender and disease..:

Cesario, S. ; Genovesi, V. ; Rimini, M....
Annals of Oncology. 35 (2024) - p. S83 , 2024

Link: https://doi.org/10.1016/..

12

Comparative analysis of subclassification models in patient..:

Ielasi, L. ; Stefanini, B. ; Conti, F....
Digestive and Liver Disease. 56 (2024) - p. S85 , 2024

Link: https://doi.org/10.1016/..

13

189P The synergic effect of metformin and atezolizumab/beva..:

Dalbeni, A. ; Auriemma, A. ; Stefanini, B....
Annals of Oncology. 35 (2024) - p. S85 , 2024

Link: https://doi.org/10.1016/..

14

The IMPROVEMENT project: first report of the global liver t..:

Avolio, A.W. ; Pascale, M.M. ; Burra, P....
Digestive and Liver Disease. 56 (2024) - p. S17-S18 , 2024

Link: https://doi.org/10.1016/..

15

Clinical impact of contrast-enhanced ultrasound on indeterm..:

Piscaglia, F. ; Kono, Y. ; Wilson, S.R....
Digestive and Liver Disease. 56 (2024) - p. S2-S3 , 2024

Link: https://doi.org/10.1016/..